Toll Free: 1-888-928-9744

Stratatech Corporation - Product Pipeline Review - 2015

Published: Jul, 2015 | Pages: 25 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Stratatech Corporation - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Stratatech Corporation - Product Pipeline Review - 2015', provides an overview of the Stratatech Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Stratatech Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Stratatech Corporation including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Stratatech Corporation's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Stratatech Corporation's pipeline products

Reasons to buy

- Evaluate Stratatech Corporation's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Stratatech Corporation in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Stratatech Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Stratatech Corporation and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Stratatech Corporation
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Stratatech Corporation and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Stratatech Corporation Snapshot 5 Stratatech Corporation Overview 5 Key Information 5 Key Facts 5 Stratatech Corporation - Research and Development Overview 6 Key Therapeutic Areas 6 Stratatech Corporation - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Stratatech Corporation - Pipeline Products Glance 10 Stratatech Corporation - Late Stage Pipeline Products 10 Phase III Products/Combination Treatment Modalities 10 Stratatech Corporation - Clinical Stage Pipeline Products 11 Phase I Products/Combination Treatment Modalities 11 Stratatech Corporation - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Stratatech Corporation - Drug Profiles 14 StrataGraft Skin Tissue 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Cathelicidin 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Cell Therapy to Activate VEGF for Venous Leg Ulcers and Diabetic Foot Ulcers 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Interleukin-12 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Stratatech Corporation - Pipeline Analysis 20 Stratatech Corporation - Pipeline Products by Target 20 Stratatech Corporation - Pipeline Products by Molecule Type 21 Stratatech Corporation - Pipeline Products by Mechanism of Action 22 Stratatech Corporation - Locations And Subsidiaries 23 Head Office 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 24 Contact Us 24 Disclaimer 25
List of Tables
Stratatech Corporation, Key Information 5 Stratatech Corporation, Key Facts 5 Stratatech Corporation - Pipeline by Indication, 2015 7 Stratatech Corporation - Pipeline by Stage of Development, 2015 8 Stratatech Corporation - Monotherapy Products in Pipeline, 2015 9 Stratatech Corporation - Phase III, 2015 10 Stratatech Corporation - Phase I, 2015 11 Stratatech Corporation - Preclinical, 2015 12 Stratatech Corporation - Discovery, 2015 13 Stratatech Corporation - Pipeline by Target, 2015 20 Stratatech Corporation - Pipeline by Molecule Type, 2015 21 Stratatech Corporation - Pipeline Products by Mechanism of Action, 2015 22



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify